GlaxoSmithKline PLC Block listing Interim Review (9474N)
May 26 2020 - 6:53AM
UK Regulatory
TIDMGSK
RNS Number : 9474N
GlaxoSmithKline PLC
26 May 2020
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
--------------------------------------------------------
Period of return: From: 1 November 2019 To: 30 April 2020
------------------------ ------------------------- ------ ---------------------
Balance of unallotted securities under scheme(s) from
previous return: 153,724
--------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 370,000
--------------------------------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): (388,348)
--------------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at
end of period: 135,376
--------------------------------------------------------
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline 2009 Share Option Plan - Ordinary Shares
-------------------------------------------------------------
Period of return: From: 1 November 2019 To: 30 April 2020
------------------------ --------------------------- ------- -----------------------
Balance of unallotted securities under scheme(s) from
previous return: 835,095
-------------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 0
-------------------------------------------------------------
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G): 581,004
-------------------------------------------------------------
Equals: Balance under scheme(s) not yet
issued/allotted at end of period: 254,091
-------------------------------------------------------------
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline 2009 Share Option Plan - ADS
-------------------------------------------------
Period of return: From: 1 November 2019 To: 30 April 2020
------------------------ ---------------------- ----- ------------------
Balance of unallotted securities under scheme(s) from previous
return: 5,391,416
-------------------------------------------------
Plus: The amount by which the block scheme(s) has been increased
since the date of the last
return (if any increase has been applied for): 0
-------------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): 698,736
-------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of
period: 4,692,680
-------------------------------------------------
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline plc Share Save Plan 2012
---------------------------------------------
Period of return: From: 1 November 2019 To: 30 April 2020
------------------------ -------------------- ----- ----------------
Balance of unallotted securities under scheme(s) from previous return: 2,145,812
---------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 0
---------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): 698,407
---------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of
period: 1,447,405
---------------------------------------------
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
---------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BLRDZGZKGVLGGZM
(END) Dow Jones Newswires
May 26, 2020 06:53 ET (10:53 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024
